Pro Share Advisors LLC Dexcom Inc Transaction History

Pro Share Advisors LLC

  • $48.7 Billion
  • Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Dexcom Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 603,787 shares of DXCM stock, worth $40 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
603,787
Previous 575,580 4.9%
Holding current value
$40 Million
Previous $39.3 Million 34.09%
% of portfolio
0.11%
Previous 0.09%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
BUY
$59.83 - $87.57 $1.69 Million - $2.47 Million
28,207 Added 4.9%
603,787 $52.7 Million
Q1 2025

May 08, 2025
BUY
$67.74 - $90.75 $4.68 Million - $6.28 Million
69,159 Added 13.66%
575,580 $39.3 Million
Q4 2024

Feb 13, 2025
BUY
$65.68 - $81.01 $4.62 Million - $5.7 Million
70,303 Added 16.12%
506,421 $39.4 Million
Q3 2024

Nov 13, 2024
BUY
$64.0 - $116.06 $2.07 Million - $3.76 Million
32,376 Added 8.02%
436,118 $29.2 Million
Q2 2024

Aug 13, 2024
SELL
$110.31 - $140.45 $3.34 Million - $4.26 Million
-30,310 Reduced 6.98%
403,742 $45.8 Million
Q1 2024

May 08, 2024
BUY
$114.22 - $140.1 $8.48 Million - $10.4 Million
74,199 Added 20.62%
434,052 $60.2 Million
Q4 2023

Feb 14, 2024
SELL
$75.49 - $124.16 $4.98 Million - $8.19 Million
-65,987 Reduced 15.5%
359,853 $44.7 Million
Q3 2023

Nov 13, 2023
BUY
$86.06 - $137.93 $4.58 Million - $7.34 Million
53,215 Added 14.28%
425,840 $39.7 Million
Q2 2023

Aug 10, 2023
SELL
$112.47 - $130.98 $2.85 Million - $3.32 Million
-25,310 Reduced 6.36%
372,625 $47.9 Million
Q1 2023

May 11, 2023
BUY
$104.0 - $122.92 $5.14 Million - $6.07 Million
49,391 Added 14.17%
397,935 $46.2 Million
Q4 2022

Feb 02, 2023
SELL
$84.98 - $122.67 $3.51 Million - $5.07 Million
-41,329 Reduced 10.6%
348,544 $39.5 Million
Q3 2022

Nov 04, 2022
SELL
$76.35 - $94.18 $6.88 Million - $8.49 Million
-90,153 Reduced 18.78%
389,873 $31.4 Million
Q2 2022

Aug 01, 2022
BUY
$67.99 - $132.89 $20.5 Million - $40.1 Million
301,899 Added 169.49%
480,026 $35.8 Million
Q1 2022

May 10, 2022
SELL
$94.08 - $130.2 $554,319 - $767,138
-5,892 Reduced 3.2%
178,127 $91.1 Million
Q4 2021

Feb 08, 2022
BUY
$129.87 - $162.82 $8.75 Million - $11 Million
67,413 Added 57.81%
184,019 $98.8 Million
Q3 2021

Nov 12, 2021
BUY
$106.71 - $143.18 $1.06 Million - $1.42 Million
9,887 Added 9.26%
116,606 $63.8 Million
Q2 2021

Aug 13, 2021
SELL
$80.99 - $107.93 $679,020 - $904,885
-8,384 Reduced 7.28%
106,719 $45.6 Million
Q1 2021

May 14, 2021
BUY
$84.79 - $104.74 $1.55 Million - $1.92 Million
18,302 Added 18.91%
115,103 $41.4 Million
Q4 2020

Feb 09, 2021
BUY
$78.0 - $104.5 $1.32 Million - $1.77 Million
16,906 Added 21.16%
96,801 $35.8 Million
Q3 2020

Nov 13, 2020
BUY
$95.51 - $112.95 $1.43 Million - $1.69 Million
14,985 Added 23.09%
79,895 $32.9 Million
Q2 2020

Aug 03, 2020
BUY
$62.68 - $105.34 $3.96 Million - $6.66 Million
63,254 Added 3819.69%
64,910 $26.3 Million
Q1 2020

May 15, 2020
SELL
$47.79 - $75.63 $25,041 - $39,630
-524 Reduced 24.04%
1,656 $446,000
Q4 2019

Feb 12, 2020
BUY
$36.62 - $57.29 $1,281 - $2,005
35 Added 1.63%
2,180 $477,000
Q3 2019

Nov 12, 2019
SELL
$35.53 - $43.8 $2,487 - $3,066
-70 Reduced 3.16%
2,145 $320,000
Q2 2019

Aug 13, 2019
SELL
$27.84 - $38.92 $38,808 - $54,254
-1,394 Reduced 38.63%
2,215 $332,000
Q1 2019

May 15, 2019
BUY
$28.07 - $38.18 $28,013 - $38,103
998 Added 38.22%
3,609 $430,000
Q4 2018

Feb 14, 2019
SELL
$26.99 - $37.37 $13,710 - $18,983
-508 Reduced 16.29%
2,611 $313,000
Q3 2018

Nov 14, 2018
BUY
$23.35 - $36.72 $23,770 - $37,380
1,018 Added 48.45%
3,119 $446,000
Q2 2018

Aug 13, 2018
BUY
$17.54 - $25.22 $36,851 - $52,987
2,101 New
2,101 $200,000

Others Institutions Holding DXCM

# of Institutions
1,110
Shares Held
368M
Call Options Held
5.32M
Put Options Held
5.18M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email